Maria Berdella

A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis

Rebecca Cosgriff, Susannah Ahern, Scott C. Bell et al. · Journal of Cystic Fibrosis · 2020 · 141 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +12

Forced Expiratory Volume in 1 Second Variability Helps Identify Patients with Cystic Fibrosis at Risk of Greater Loss of Lung Function

Wayne J. Morgan, Donald R. VanDevanter, David J. Pasta et al. · The Journal of Pediatrics · 2015 · 60 citations

Health Professions, Clinical Sciences, Physiology +16

Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis

Emily DiMango, Patricia Walker, Claire Keating et al. · BMC Pulmonary Medicine · 2014 · 52 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study

Patrick A. Flume, Reta Fischer Biner, D.G. Downey et al. · The Lancet Respiratory Medicine · 2021 · 51 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Clinical Sensitivity of Cystic Fibrosis Mutation Panels in a Diverse Population

Erin E. Hughes, Colleen F. Stevens, Carlos A. Saavedra‐Matiz et al. · Human Mutation · 2015 · 43 citations

Medicine, Genetics, Molecular Genetics +17